IJMS manuscript!

01/01/2022

In collaboration with Rommier, Schutkowski, Krammer, and Sippl groups, we contributed our expertise in protein biochemistry and heterologous expression to the manuscript describing the development of novel class I selective HDAC inhibitors with anti-leukemic activity. A very nice collaborative story!

News